Fetal glucose availability: a key regulator of the metabolic, hormonal and contractility profiles of the fetal sheep heart
The Journal of Physiology · 2025
DOI: 10.1113/jp288303 ↗At a glance
Journal article in The Journal of Physiology, 2025. Written by Melanie R Bertossa and 10 co-authors. Institution: Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, A…. Major MEDLINE topics: Fetal Heart, Glucose, Fetal Growth Retardation, Myocardial Contraction. Cited 1 times so far (Crossref); 115 references. The full text is freely available (open access, CC BY 4.0). Funded by: Australia Research Council Future Fellowship Level 3, MRB is funded by an Australian Research Training Program Scholarship.
Abstract (original language)
There is an association between fetal growth restriction (FGR) and a poor lifetime cardiac health trajectory. Defining the underlying mechanisms will aid in developing interventions to decrease the contribution of FGR‐born offspring to the global burden of cardiovascular disease. One cause of FGR is maternal undernutrition. In late‐gestation undernutrition (LGUN) fetal glucose supply, a main energy source for the fetal heart, is reduced. This may be a key contributor to altered fetal cardiac development; thus restoration of fetal glucose availability in the LGUN setting may be a viable target for intervention. To investigate the role of glucose availability in fetal heart development, we utilized an established pregnant sheep model of LGUN (50% global nutrient restriction) with or without a continuous intrafetal glucose infusion. LGUN reduced fetal plasma glucose concentrations, resulting in brain sparing that was normalized by intrafetal glucose infusion. LGUN decreased the protein abundance of oxidative phosphorylation complexes 1 and 3; however glucose infusion returned complex 3 abundance to that of controls. LGUN increased the phosphorylation of contractility and hypertrophy marker CAMKII, which was associated with increased left ventricular cardiac output; however intrafetal glucose infusion normalized CAMKII. Our findings demonstrate that glucose plays a specific role in regulating cardiac development in utero , highlighting the importance of adequate maternal nutrition in late gestation. image Key points Maternal late‐gestation undernutrition (LGUN) reduces fetal plasma glucose concentrations. To investigate the role of glucose availability in fetal left ventricle (LV) development, we assessed whether LGUN‐induced alterations in the contractility, metabolic and hormonal profiles can be ameliorated in LGUN fetuses receiving glucose infusion (LGUN+G). Relative brain weight was increased in LGUN compared to controls and restored in LGUN+G despite fetal glucose infusion only partially normalizing fetal plasma glucose concentrations to that of controls. LGUN decreased cardiac oxidative phosphorylation (OXPHOS)complex 1 and 3 abundance, and LGUN+G restored complex 3 to that of controls. LGUN increased the activation of the contractility marker, Ca 2+ /calmodulin‐dependent protein kinase II (p‐CAMKII), but restored in LGUN+G. The magnetic resonance imaging measure of the LV cardiac output was positively correlated with p‐CAMKII expression in LGUN. This study highlights the role of in utero glucose availability in regulating the abundance of fetal LV OXPHOS complex 3 and CAMKII activation in utero .
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
- Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Canada.
- Translational Medicine, Hospital for Sick Children, Toronto, Canada.
- Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Canada.
- Division of Cardiology, Hospital for Sick Children, Toronto, Canada.
- Department of Paediatrics, Faculty of Medicine, University of Toronto, Toronto, Canada.
ORCID profiles: Melanie R Bertossa, Jack R T Darby, Stacey L Holman, Steven K S Cho, Ashley S Meakin, Mitchell C Lock, Jordan A Minns, Christopher K Macgowan, Mike Seed, Janna L Morrison
Funding
- Australia Research Council Future Fellowship Level 3
- MRB is funded by an Australian Research Training Program Scholarship
Cite
APA
Bertossa, M. R., Darby, J. R. T., Holman, S. L., Cho, S. K. S., Meakin, A. S., Lock, M. C., Minns, J. A., Wiese, M. D., Macgowan, C. K., Seed, M., & Morrison, J. L. (2025). Fetal glucose availability: a key regulator of the metabolic, hormonal and contractility profiles of the fetal sheep heart. The Journal of Physiology. https://doi.org/10.1113/jp288303
Vancouver
Bertossa MR, Darby JRT, Holman SL, Cho SKS, Meakin AS, Lock MC, et al. Fetal glucose availability: a key regulator of the metabolic, hormonal and contractility profiles of the fetal sheep heart. The Journal of Physiology. 2025. doi:10.1113/jp288303
BibTeX
@article{Bertossa2025,
author = {Bertossa, Melanie R and Darby, Jack R T and Holman, Stacey L and Cho, Steven K S and Meakin, Ashley S and Lock, Mitchell C and Minns, Jordan A and Wiese, Michael D and Macgowan, Christopher K and Seed, Mike and Morrison, Janna L},
title = {Fetal glucose availability: a key regulator of the metabolic, hormonal and contractility profiles of the fetal sheep heart},
journal = {The Journal of Physiology},
year = {2025},
doi = {10.1113/jp288303}
}
EUVIMED